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Abstract
Immunological checkpoints, such as the inhibitory CD200 receptor (CD200R), play a dual role in balancing the immune
system during microbial infection. On the one hand these inhibitory signals prevent excessive immune mediated pathology
but on the other hand they may impair clearance of the pathogen. We studied the influence of the inhibitory CD200-
CD200R axis on clearance and pathology in two different virus infection models. We find that lack of CD200R signaling
strongly enhances type I interferon (IFN) production and viral clearance and improves the outcome of mouse hepatitis
corona virus (MHV) infection, particularly in female mice. MHV clearance is known to be dependent on Toll like receptor 7
(TLR7)-mediated type I IFN production and sex differences in TLR7 responses previously have been reported for humans. We
therefore hypothesize that CD200R ligation suppresses TLR7 responses and that release of this inhibition enlarges sex
differences in TLR7 signaling. This hypothesis is supported by our findings that in vivo administration of synthetic TLR7
ligand leads to enhanced type I IFN production, particularly in female Cd200
2/2 mice and that CD200R ligation inhibits TLR7
signaling in vitro. In influenza A virus infection we show that viral clearance is determined by sex but not by CD200R
signaling. However, absence of CD200R in influenza A virus infection results in enhanced lung neutrophil influx and
pathology in females. Thus, CD200-CD200R and sex are host factors that together determine the outcome of viral infection.
Our data predict a sex bias in both beneficial and pathological immune responses to virus infection upon therapeutic
targeting of CD200-CD200R.
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Introduction
To generate an appropriately controlled response during infec-
tions, the immune system is balanced by the action of activating and
inhibitory receptors. Lack of inhibition leads to excessive inflamma-
tion and autoimmunity and other severe disease symptoms. One of
the receptors regulating this balance is CD200 Receptor (CD200R)
[1]. CD200R was originally described as a myeloid receptor [2],
being expressed on macrophages, granulocytes and DCs, but later
we and others recognized that it is also expressed on T cells, B cells
and NK cells [3,4]. The CD200R intracellular domain is devoid of
the classical immunoreceptor tyrosine-based inhibition motif (ITIM)
present in most immune inhibitory receptors but it does have three
tyrosine residues that can be phosphorylated, one of which is
embedded in an NPXY motif. CD200R-downstream signaling is
dependent on the recruitment of Dok2 and RasGAP [5].
The signal that triggers CD200R and results in delivery of an
inhibitory intracellular signal to the cell is given by its ligand CD200,
which has a short intracellular tail devoid of any known signaling
motifs. CD200 is expressed on thymocytes, activated T cells, B cells,
dendritic cells (DCs), vascular endothelial cells, hair follicular cells, in
the central nervous system and in the retina (reviewed in [6]). Both in
mice and humans, CD200 exclusively binds to the inhibitory
CD200R. In contrast to humans, the mouse CD200R family contains
several activating receptors, but these do not bind CD200 [7].
Cd200
2/2 mice were first described to be more susceptible to
autoimmune disorders [8]. Later its role in microbial infections
was recognized. Infection of Cd200
2/2 mice with the gram
negative N. meningitides causes increased lethality, proinflammatory
cytokine production and lymphocyte activation [9]. We and others
showed that in mouse influenza A virus infection CD200-
deficiency aggravates immune pathology [10,11]. These studies
were exclusively performed in female mice. They indicate that
CD200-CD200R signaling controls the strength of the initial anti-
microbial response and the return to homeostasis. We here studied
the influence of CD200-CD200R blockade on clearance and
pathology in two different virus infection models, coronavirus and
influenza virus, in both male and female mice.
PLoS Pathogens | www.plospathogens.org 1 May 2012 | Volume 8 | Issue 5 | e1002710Mouse hepatitis coronavirus (MHV) is an accepted model for the
most illustrious coronavirus (CoV): severe acute respiratory syndrome
(SARS)-CoV. Host control of MHV infection is completely
dependent on an immediate type I IFN response, initiated upon
TLR7 triggering by viral RNA. Mice lacking this pathway show
massive MHV replication and fatal infection within a few days
[12,13]. As a model where a strong anti-viral response causes immune
mediated pathology we studied influenza A virus infection in which
immune pathology is known to be important for clinical outcome.
We here report that lack of CD200R signaling has a more
profound effect on the beneficial but also on the pathological
immune responses to viruses in female mice as compared to male
mice, which can be attributed to the capacity of CD200R to
inhibit TLR7 responses.
Results/Discussion
CD200-deficiency and sex determine the outcome of
MHV infection
To determine the role of CD200-CD200R signaling in CoV
infection, we intraperitoneally inoculated male and female wild type
(WT) and Cd200
2/2 mice with a recombinant MHV encoding
luciferase (MHV-EFLM). We monitored viral spread using
bioluminescence imaging (BLI) at day 2 and 4 after infection
[14,15]. Interestingly, at both time points we observed a decreased
viral spread in female WT mice when compared to males.
Moreover, lack of CD200 resulted in a significantly lower level of
viral replication in females (Figure 1A,B and Figure S1A,B,C).
The viral RNA load in the livers at day 4 was assessed by
quantitative PCR and confirmed the imaging results: WT female
mice had significantly lower viral RNA levels than WT male mice
(Figure 1C). Again, CD200-deficiency greatly decreased virus load
in female mice. This was confirmed in histological liver sections
stained witha monoclonal antibody against MHV (data not shown).
The number of focal lesions in the liver, typical for MHV was also
lower in female mice and again CD200-deficiency had a significant
effect on these lesions only in female mice (Figure 1D,E).
Clearance of MHV critically depends on TLR7-mediated type I
IFN production by hematopoietic cells [12,13]. In WT mice, MHV
infection resulted in detectable IFN-a production only in female
mice (Figure 2A). In Cd200
2/2 animals, all females and 2 out of 8
males produced detectable amounts ofIFN-a and Cd200
2/2 female
mice produced the highest amounts of IFN-a (Figure 2A). IFN-a
concentrations in serum inversely correlated with viral load at day 4
(p=0.04) (data not shown). Thus, the combination of female sex
and CD200 deficiency results in increased type I IFN production
and decreased viral load and pathology upon MHV infection.
Enhanced TLR7 responses in female Cd200
2/2 mice
Sex differences in TLR7 responses have previously been
reported for humans [16,17]. Our observed sex difference in
IFN-a production and viral clearance upon MHV infection in
mice is likely due to a similar sex bias in TLR7 responses. We
hypothesized that CD200R signaling suppresses TLR7 responses
in WT mice. Release of this inhibition would further reveal the
intrinsically higher TLR7 responses in females and result in more
rapid viral clearance. To test this hypothesis, we first administered
a TLR7 ligand in vivo. As described previously [18], intraperitoneal
injection of a synthetic TLR7 ligand (imiquimod) leads to rapid
release of type I IFN into the circulation. One-hour after injection
we only detected significant amounts of IFN-a in the sera of female
Cd200
2/2 mice, confirming the notion that CD200R inhibits the
intrinsic potential for a higher TLR7 response in females
(Figure 2B). We sacrificed the mice at 24 hrs after ligand
injection, at which time point no serum IFN-a was detectable (data
not shown) but type I IFN mRNA could be detected in the livers of
these mice. Again, females expressed more IFN-b mRNA than
males, with CD200-deficient female mice displaying even more
elevated IFN-b mRNA levels (Figure 2C). Thus, release of
CD200-mediated inhibition leads to increased production of type I
IFN in response to TLR7 ligands, particularly in female mice.
CD200R inhibits TLR7 signaling
We next tested whether CD200R-mediated signaling directly
inhibits signals transduced via TLR7. We generated a chimeric
construct containing a LAIR-1 receptor in which the intracellular
tail was replaced by that of CD200R. This allows for efficient
cross-linking using anti-LAIR-1 antibodies to induce signaling via
the CD200R cytoplasmic tail. We transfected HEK 293 cells with
plasmids encoding a LAIR-1-CD200R chimeric receptor, human
TLR7 and a luciferase reporter under control of a NF-kB driven
promoter. Cross-linking of the chimeric receptor by anti-LAIR-1
antibody, but not by isotype-matched control antibody, resulted in
robust inhibition of imiquimod-induced NF-kB activity
(Figure 3A). CD200R contains three intracellular tyrosine
residues. A chimeric LAIR-1-CD200R protein in which all three
tyrosines are mutated to phenylalanine (FFF) did not suppress
TLR7 responses upon cross-linking, indicating that the observed
inhibitory effect is indeed dependent on CD200R-signaling
(Figure 3A). In a cell line with stable ectopic expression of
TLR7 and transient expression of the NF-kB-reporter and the
LAIR-1-CD200R constructs we also observed that TLR7
signaling was inhibited through CD200R-mediated signaling. A
similar effect was observed when luciferase expression was driven
by an IFN-b promoter (Figure 3B). Thus, the enhanced type I
IFN production and viral clearance of MHV in female Cd200
2/2
mice can be explained by the release of CD200R-mediated
inhibition of the intrinsically higher TLR7 responses in females.
Sex-bias in viral clearance and pathology in influenza
virus infected mice
A strong anti-viral response can also cause immune mediated
pathology that can be detrimental to the host. We therefore moved
to a virus infection model in which immune pathology is known to
Author Summary
Immune responses need to be carefully orchestrated to
prevent disease due to an overactive immune system.
Immunological checkpoints are provided by immune
inhibitory receptors, which set a threshold for activation
and dampen the immune system. In the case of a viral
infection, this prevents pathology induced by the immune
system, but on the other hand may prevent adequate
removal of the virus. In this paper, we show that removal
of such an immunological checkpoint in mice leads to
rapid removal of corona virus, but also to more immune-
induced disease symptoms in case of influenza virus
infection. We observe this predominantly in female mice.
We demonstrate that this particular checkpoint inhibits
anti-viral responses that are naturally stronger in females.
Release of this checkpoint enlarges these sex differences.
Our findings have major implications for therapeutic use of
blockers of this pathway, which are currently in clinical
trials for the treatment of cancer, as we predict that
female patients will have a stronger response to such
therapeutics.
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influenza A virus we again observed a sex bias in the viral load,
measured in the lungs at day 8 post infection (Figure 4A). Female
mice had lower viral loads compared to male mice, which was
accompanied by enhanced IFN-a concentrations in the broncho-
alveolar lavage (BAL) fluid (Figure 4B). However, as opposed to
MHV infection, CD200-deficiency did not enhance type I IFN
production in influenza virus infection (Figure 4B).
Confirming previous reports, we found a significantly enhanced
body weight loss in female Cd200
2/2 mice compared to WT
Figure 1. CD200-deficiency and sex determine the outcome of MHV infection. A Male and female WT (open bars) and Cd200
2/2 (gray bars)
mice (n=7 per group) were intraperitoneally inoculated with CoV (MHV-EFLM). At day 4 after infection mice were injected intraperitoneally with
luciferin and were subjected to BLI. Integrated light intensity is shown. Results are representative of three independent experiments. Uninfected mice
did not give a BLI signal. B Quantification of the data in (A). C Four days after infection mice were sacrificed, RNA was isolated from livers and fold-
difference in viral RNA was measured by qRT-PCR. D Livers from mice 4 days post-infection were fixed and stained with hematoxylin and eosin.
Cellular infiltration foci were quantified in the whole liver sections, (n=7). In (B–D) mean 6 SEM is shown. Statistical significance was calculated with a
Mann-Whitney test. ns=not significant. *=p,0.05. **=p,0.01. ***=p,0.005. E Representative example of single foci from livers of mice 4 days
after infection, (n=7). Similar results were obtained in 3 independent experiments.
doi:10.1371/journal.ppat.1002710.g001
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2/2 mice lost
more weight than WT males, the weight loss started later and the
difference was not as prominent (Figure 4D). This may indicate
that lack of CD200 results in a more severe pathology in females.
We observed an increased level of cellular infiltration in lung tissue
of females (Figure S2A). Therefore we determined lung cellular
influx by differential cell count in BAL fluid (Figure S2B–D). The
total number of cells in BAL fluid was higher in all female groups
but differences were not significant (Figure S2B). The number of
lymphocytes was increased in females of both genotypes (Figure
S2D). At day 4 after infection, the number of lymphocytes was
increased in females of both WT and Cd2002/2 groups. At day
8, the number of neutrophils in the BAL fluid was decreased in all
groups, still the WT females displayed elevated numbers over
males. Importantly, lack of CD200 resulted in significantly higher
neutrophil counts in females but not in males (Figure 4E). As an
additional parameter of lung damage we measured the total
protein content in the BAL fluid. Lack of CD200 resulted in
increased protein levels in the BAL fluid of both males and
females, especially at day 8 after infection (Figure 4F). Overall
these data indicate that female mice experience increased lung
pathology upon influenza A virus infection, which is aggravated by
the lack of the CD200R-regulatory pathway.
In agreement with the increased neutrophil counts we measured
elevated levels of KC (IL-8) in the BAL fluid (Figure 4G). IL-6
concentrations were increased in all females at 4 and 8 days after
infection, which was further enhanced by the lack of CD200 only
at day 4 (Figure 4H). TNF-a was hardly detectable, but
significantly increased levels were measured in Cd200
2/2 female
mice at day 4 after infection (Figure 4I).
Thus, from two different viral infection models we can conclude
that sex has a profound effect on type I IFN production and viral
clearance. This study is the first to report a significantly enhanced
viral clearance in female mice due to a sex bias in TLR7 responses.
Sex differences in TLR7 induced type I IFN production have
previously been reported for humans [16,17] and our data show
that in mice this has a strong impact on the course of a viral
infection. The mechanism for this is not understood. On the one
hand, incomplete inactivation of the Tlr7 gene, on the X
chromosome, resulting in higher TLR7 expression in females
has been proposed [19,20]. In our experiments, TLR7 mRNA
expression was equal in male and female mice (Figure S3). This is
consistent with a prior report in which no evidence for escape from
X-inactivation of the Tlr7 gene in humans was found [16]. There
are conflicting reports concerning the influence of sex hormones
on TLR7 responses [16,17]. Alternatively, sex-dependent epige-
netic mechanisms may contribute [16].
We demonstrate direct inhibition of TLR7 signaling through
CD200R. Previously, CD200R-mediated inhibition of LPS-
induced cytokine production was reported [5,21,22]. This suggests
that CD200R affects proximal events in the TLR signaling
pathway. CD200R is a unique inhibitory receptor, since its
intracellular tail does not contain ITIMs. CD200R does contain
three intracellular tyrosine residues. Mutation of all three tyrosine
completely abrogates its inhibitory function [23]. The most distal
tyrosine is located in an NPXY motif, to which the adaptor
molecule Dok2 is recruited [24]. Dok 2 activates RasGAP and
knockdown of these proteins diminishes the inhibitory action of
CD200R [5]. However, the down-stream targets for CD200R
mediated inhibition are not yet identified.
Upon influenza A virus infection, CD200-deficiency strongly
enhances neutrophil influx into the lungs of female mice possibly
leading to pathology, but it does not affect viral clearance and type
I IFN production. This implies that, for influenza virus, the sex-
biased type I IFN production and viral clearance are not regulated
by CD200R, while the events leading to increased neutrophil
recruitment and lung pathology are. Neutrophil responses to
influenza virus infection were shown to be dependent on TLR7
[25]. Since neutrophils express CD200R, the strongly increased
neutrophil influx in female Cd200
2/2 mice is in line with our
finding that CD200R inhibits sex-biased TLR7 responses. In
contrast to MHV infection, clearance of influenza A virus is not
dependent on plasmacytoid dendritic cells [26]. Although influ-
enza RNA triggers TLR7 [27], the main source of type I IFN is
the infected respiratory epithelium [28]. These cells do not express
Figure 2. Enhanced type I interferon responses in female
Cd200
2/2 mice. A IFN-a concentrations in the sera of male and female
WT (open bars) and Cd200
2/2 (gray bars) mice were measured by ELISA.
Naı ¨ve mice (n=4) and mice at 4 days post-infection with coronavirus
(MHV-EFLM) (n=7) were used. B Male and female WT (open bars) and
Cd200
2/2 (gray bars) mice were injected intraperitoneally with the TLR7
ligand imiquimod (50 mg/mouse). One-hour later sera were collected,
and the concentrations of IFNa were measured by ELISA (n=6). Dotted
lines in (A,B) indicate the detection limit of the ELISA. C Male and female
WT (open bars) and Cd200
2/2 (gray bars) mice were injected
intraperitoneally with the TLR7 ligand imiquimod (50 mg/mouse).
Twenty-four hours later livers were collected and IFNb expression was
determined by qRT-PCR (n=6). Mean 6 SEM is shown. Statistical
significance was calculated with Mann-Whitney test. ns=not significant.
*=p,0.05. **=p,0.01. ***=p,0.005.
doi:10.1371/journal.ppat.1002710.g002
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explaining the lack of effect of CD200-deficiency on type I IFN
production.
There is emerging evidence that tumor cells employ immuno-
logical checkpoints for their benefit. As a result of this, inhibitory
immune pathways have become therapeutic targets to strengthen
anti-tumor responses and develop (adjuvant) therapeutic strategies
in cancer treatment. The successful application of anti-CTLA4
(Cytotoxic T-Lymphocyte Antigen 4) in melanoma is followed up
with blocking agents for other checkpoints, among which the
CD200-CD200R immune inhibitory pathway. Strong evidence
for a role for CD200 in tumor progression comes from studies in
patients. Expression of CD200 is an independent prognostic factor
for multiple myeloma and acute myeloid leukemia predicting
worse overall survival of these patients [29,30]. A clinical trial with
a blocking anti-CD200 antibody aims to enhance anti-tumor
responses towards CD200-expressing malignancies (Clinical-
Trials.gov Identifier: NCT00648739). On the basis of our data,
one of the predicted side effects would be severe immune
pathology to infections.
Our finding that the combination of lack of CD200R signaling
and female sex has such a profound impact on the control of virus
infection as well as on immune pathology raises some important
issues. We are the first to demonstrate a strong sex bias in type I
IFN production and viral clearance in mice utilizing two different
models of virus infection. This is of importance for scientists
studying these widely used models and may result in a completely
different interpretation of data obtained, depending on the sex of
the mice used. Moreover, sex biased clinical responses to virus
infections have been reported in humans [31]. For influenza A
virus (H5N1) a significantly enhanced case-fatality rate was found
in women [32]. In agreement with these findings we now show
increased lung damage, enhanced neutrophil influx and elevated
IL-8, IL-6 levels in BAL fluid of female mice upon influenza A
virus infection. A few reports discuss the possibility of a sex bias in
severity of SARS-CoV infection [33,34]. Also for HIV-1 infection,
sex-related differences have been well-established [35,36]. Our
results underscore the importance of the issue of sex bias in
scientific research, clinical trails, and vaccine studies, previously
raised by others [19,37]. Particularly, CD200 blocking antibodies
are currently entering clinical trials for cancer treatment. Our data
point to a possible pathological outcome of e.g. influenza virus
infection in women as a result of CD200 blocking therapies.
Materials and Methods
Mice and viruses
Wild-type C57BL/6J mice and Cd200
2/2 mice, which were
made and maintained on a full C57BL/6J background [8], were
bred at the Specified Pathogen Free (SPF) unit at the Utrecht
University Central Animal Laboratory and used between 8 and 10
weeks of age. Mice were injected intraperitoneally with 10
6
TCID50 of MHV strain A59 expressing the firefly luciferase (FL)
reporter gene (MHV-EFLM) [14] in 200 ml PBS. Intranasal
infection with 3.0610
4 TCID50 of influenza strain A/HK/2/68
was performed as described [11]. Mice were monitored once every
24 hours for symptoms of illness.
In additional experiments we injected the mice intraperitoneally
with the TLR7 agonist imiquimod (Invivogen; 50 mg in 200 ml
PBS). The Utrecht University Ethical Committee for Animal
Experimentation approved the animal study protocols, in accor-
dance with the advice of the Central Committee on Animal
Experimentation (20 januari 1997) and the Dutch Law on Animal
Experimentation (art. 18a).
Bioluminescence imaging
After MHV-EFLM injection (day 0), mice were imaged at day 2
and day 4 as described previously [14] with minor modifications.
Briefly, mice were anaesthetized with isoflurane and subsequently
injected with 100 ml of the FL substrate D-luciferin (Synchem
Figure 3. Stimulation of CD200R directly inhibits TLR mediated NFkB activity. A HEK 293 T cells were transiently transfected with TLR7, NF-
kB luciferase reporter and LAIR-1-CD200R chimera or signaling-defective LAIR-1-CD200R-FFF constructs. Twenty-four hours later cells were stimulated
with control or anti-LAIR-1 antibody. Forty-eight hours after transfection cells were stimulated with the TLR7 ligand imiquimod (3.0 mg/ml). Seventy-
two hours after transfection cells were harvested, luciferase activity, and total protein content were determined. Protein normalized, luciferase activity
from 3 independent experiments is shown. B HEK 293 T cells with stable expression of TLR7 were transiently transfected with a NF-kB luciferase
reporter construct or an IFNb luciferase reporter construct and a LAIR-1-CD200R chimera. TLR7 stimulation and CD200R crosslinking was performed
as in (A). Protein normalized with luciferase activity from 3 independent experiments is shown. Mean 6 SEM is shown. Statistical significance was
calculated with Mann-Whitney test. ns=not significant. *=p,0.05.
doi:10.1371/journal.ppat.1002710.g003
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were positioned to the ventral side in a specially designed box and
placed onto the stage inside the light-tight photon imager
(Biospace Laboratory). Five mice were imaged simultaneously
exactly 5 min after the injection of D-luciferin. The biolumines-
cence signals were acquired with PhotoVision software (Biospace
Laboratory) over a 10-min interval and are expressed as integrated
light intensity (photons/min). A low-intensity visible light image
was generated and used to create overlay (heatmap) images for
each individual animal.
Figure 4. CD200-deficiency and sex determine the outcome of influenza A virus infection. Naı ¨ve or influenza A virus-infected mice were
sampled at indicated time points. A Relative amounts of viral RNA in the lungs were determined by qRT-PCR. B IFNa concentration in the BAL fluid
was determined by ELISA. The dotted line indicates the detection limit. C, D Body weight of infected female (C) and male (D) Cd200
2/2 mice (filled
symbols) and WT mice (open symbols) as percentage of the weight at day of infection. E Quantification of neutrophil numbers in BAL fluid by
differential cell count. F Quantification of the total protein content in BAL fluid. Concentrations of KC (IL-8) (G), IL-6 (H) and TNFa (I) in the BAL fluid
were measured by ELISA. In all panels mean 6 SEM is shown, statistical significance was calculated with Mann-Whitney test. *=p,0.05, **=p,0.01.
doi:10.1371/journal.ppat.1002710.g004
CD200R Controls Sex-Specific Responses
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Whole livers or left lungs were dissected from the mice. The
tissues were processed in Lysing Matrix D tubes (MP Biomedical),
containing 1 ml of PBS, using a FastPrep instrument (MP
Biomedical). The tissues were homogenized at 33006 g for
40 sec and immediately placed on ice. Subsequently, the
homogenates were centrifuged at 186006 g for 10 minutes at
4uC and supernatants were harvested and stored at 280uC. Total
RNA was isolated from the homogenates using the TRIzol reagent
(Invitrogen) according to manufacturer’s instructions.
Quantitative RT-PCR
Gene expression levels of IFN-a,I F N - b1, and TLR7 were
measured by quantitative PCR using LightCycler 480 RNA Master
Hydrolysis Probes in combination with a LightCycler 480 system
(both from Roche Applied Science), according to the manufacturer’s
instructions. The housekeeping gene GAPDH was used as a
reference in all experiments, and expression of this gene was found
relatively constant among samples. The amounts of MHV RNA
were determined by quantitative RT-PCR using primers and probe
directed against the N gene of MHV-A59 [38]. For the influenza
RNA quantification the primers mapping to the influenza A
nucleoprotein (N) gene were used. Amplification and detection were
performed with an ABI Prism 7700 system. Samples were controlled
for thepresenceofpossibleinhibitorsofthe amplification reaction by
internal control (murine encephalomyocarditis virus DNA).
Bronchoalveolar lavage analysis
Bronchoalveolar lavage (BAL) fluid was obtained by flushing the
lungs two times with 1 ml PBS using a canula inserted into the
trachea, yielding around 1.7 ml BAL fluid. Pelleted cells from BAL
fluid were counted and cytospins were prepared and stained with
May-Grunwald/Giemsa and neutrophils were scored on the basis
of morphology (Dade Behring, Switzerland). BAL fluids were kept
on ice or stored at 280uC until further processing. BAL fluid was
centrifuged, and 20 ml of aliquot was used to determine the protein
concentration with a BCA kit (Pierce) according to the manufac-
turer’s instructions.
Cytokine analysis
To measure the interferon concentration in the sera, blood was
sampled from naı ¨ve mice or four days after MHV infection or one
hour after imiquimod treatment. Sera were separated by spinning
the blood at 23006g for 15 minutes at 4uC. For measurement of
cytokines in BAL, samples were prepared by spinning 5 minutes at
5306 g. IFN-a was measured with a mouse interferon alpha
ELISA kit (PBL Interferon Source). For the IL-6, IL-8 and TNF-
alpha measured by Mouse IL-6 Mni ELISA Development Kit,
Murine KC (IL-8) ELISA Development Kit and Murine TNF-
alpha Mini ELISA Development Kit (PeproTech) respectively.
Experiments were done according to manufacturer’s instructions.
Liver histopathology
Livers of MHV-infected mice were sampled, fixed in 4% neutral
buffered formalin, and embedded in paraffin. Seven mm liver
sections were stained with hematoxylin and eosin. Total liver
sections were examined by light microscopy and foci of
hepatocellular necrosis and inflammation were scored in a semi-
quantitative manner.
Reporter assays
HEK 293 T cells were transiently co-transfected with: human
TLR7 (kindly provided by Rogier Sanders, AMC, Amsterdam, the
Netherlands), and NF-kB-reporter or IFNa-reporter constructs,
kindly provided by Dr Paul Moynagh (National University of
Ireland). A chimeric construct containing the extra cellular region
of human LAIR-1 (amino acids 1–160) fused with the transmem-
brane and intracellular rat CD200R (rCD200R) (amino acids
236–327) was cloned into pcDNA3.1/zeo (Invitrogen, Breda, the
Netherlands). A tyrosine (Y) to phenylalanine (F) mutant of
tyrosines 287, 290, and 298 in the intracellular rCD200R tail were
generated with PCR-based mutagenesis. The mutant was cloned
into the same vector and all sequences were confirmed by
automated DNA sequencing. The LAIR-CD200R plasmid was
co-transfected with the TLR7 and reporter constructs. Twenty-
four hours after transfection cells were trypsinized and seeded in
48-well plates coated with 3 ug/ml anti-LAIR-1 monoclonal
antibody (clone 8A8). Forty-eight hrs after transfection cells were
stimulated with imiquimod 3 mg/ml (Invivogen) in PBS. On the
next day, cells were lysed with Passive Lysis Buffer (Promega),
luciferase activity was measured on a luminometer (Berthold
technologies Centro LB 960), and data were analyzed with
Microwin software. Total protein content was determined with a
Pierce BCA Protein Assay (Thermo Scientific). All luciferase values
were normalized to protein concentration. Alternatively, we used
HEK 293 cells stably expressing human TLR7 (Invivogen).
Statistical analysis
Significance was calculated with Mann-Whitney test using
GraphPad Prism software.
Online supplemental material
Figure S1 shows BLI measurement in naı ¨ve mice and viral
spread of MHV at day 2 after infection. Figure S2 depicts the
quantification of lung pathology and differential cell count in the
BAL fluid in influenza A virus infected mice. Figure S3 is a
quantitative analysis of TLR7 mRNA in male and female mice.
Supporting Information
Figure S1 CD200-deficiency and sex determine the
outcome of MHV infection. (A) Uninfected WT and
Cd200
2/2 mice were injected intraperitoneally with luciferin
and were subjected to bioluminescence imaging (BLI). Presented
pictures are integrated images of normal light picture and
luciferase signal. (B) At day 2 after infection with CoV (MHV-
EFLM) mice were injected intraperitoneally with luciferin and
were subjected to BLI. Integrated light intensity is shown. Results
are representative of three independent experiments. (C) Quan-
tification of the data in (B). Mean 6 SEM is shown.
(DOC)
Figure S2 Sex determines lung pathology and cellular
infiltration after influenza infection. (A) At day 8 after
influenza infection lungs were sampled and H&E stained. The
nuclear lung surface area was used as a benchmark of the
inflammatory response, its color range selections were measured
thrice. The relative nuclear surface area (nuclear surface area/lung
surface area * 100) of the lung sections was used as a measure of
the tissue response to exposure to the influenza virus (B) Total cell
count in BAL fluid. Quantification of monocyte (C) and
lymphocyte (D) numbers in BAL fluid by differential cell count.
In all panels mean 6 SEM is shown, statistical significance was
calculated with Mann-Whitney test. *=p,0.05, **=p,0.01.
(DOC)
Figure S3 No sex difference in expression of TLR7
mRNA. Four days after MHV injection mice were sacrificed,
CD200R Controls Sex-Specific Responses
PLoS Pathogens | www.plospathogens.org 7 May 2012 | Volume 8 | Issue 5 | e1002710RNA was isolated from livers and TLR7 mRNA expression was
quantified by qPCR in male and female WT and Cd200
2/2 mice.
Mean 6 SEM is shown.
(DOC)
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